Early Enteral Nutrition for Severe Acute Pancreatitis

Sponsor
Sichuan Academy of Medical Sciences (Other)
Overall Status
Completed
CT.gov ID
NCT00995098
Collaborator
Peking Union Medical College Hospital (Other)
42
1
2
12
3.5

Study Details

Study Description

Brief Summary

There is increasing evidence that indicates early enteral nutrition may be associated with improved outcome in acute pancreatitis patients. However, most of the clinical trials regarding this targeted mild to moderated pancreatitis patients. In regard to severe acute pancreatitis (SAP) patients, current results from randomized control trials (RCTs) are inconclusive. The researchers of this study aim to investigate the impact of early enteral nutrition on the clinical outcomes of SAP patients.

Condition or Disease Intervention/Treatment Phase
  • Dietary Supplement: early enteral nutrition
  • Dietary Supplement: Parenteral nutrition
Phase 4

Study Design

Study Type:
Interventional
Actual Enrollment :
42 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
The Impact of Early Enteral Nutrition on the Clinical Outcomes of Severe Acute Pancreatitis Patients: A Randomized Control Trial
Study Start Date :
Oct 1, 2009
Actual Primary Completion Date :
Jul 1, 2010
Actual Study Completion Date :
Oct 1, 2010

Arms and Interventions

Arm Intervention/Treatment
Experimental: Early enteral nutrition

Twenty patient will be enrolled into this arm. Enteral nutrition administration will start within 24 hours after admission through naso-jejunal tube and continue for 7 days after admission.Naso-jejunal tube will be set up by endoscopy.

Dietary Supplement: early enteral nutrition
Enteral nutrition will be administered within 24 hours of admission through naso-jejunal tube and continue for 7 days after admission. Naso-jejunal tube will be set up by endoscopy. X-ray will be used to place the distal end of the feeding tube and EN would not start until the distal end of the feeding tube has been placed at the remote end of Treitz ligament. Standard enteral nutrition liquid regimen (Nutrison Fibre) will be used. Patients are targeted to receive calories for 25 kcal/kg/day and nitrogen for 0.2g/kg/day.
Other Names:
  • Nutrison Fibre
  • Active Comparator: Control: Parenteral Nutrition

    Twenty patient will be enrolled into this arm. PN administration will start within 24 hours after admission and continue for 7 days after admission.Parenteral nutrition will be administered through subclavian central venous catheter.

    Dietary Supplement: Parenteral nutrition
    PN administration will start within 12 hours of admission and continue for 7 days after admission. Patients will receive calories for 25 kcal/kg and nitrogen for 0.2g/kg. Twenty percent of the calories will be provided by fat emulsion (LCT/MCT) and the remaining will be provided by dextrose. Nitrogen will be provided by balanced amino acids injection (Novamin). All PN components will be compounded into 3-liters bags under sterile conditions. Nutrition regimen will be administered through subclavian central venous catheter.
    Other Names:
  • Lipovenoes(LCT/MCT fat emulsion, 20%)
  • Novamin (11.4%)
  • Outcome Measures

    Primary Outcome Measures

    1. All cause mortality [Three months]

    Secondary Outcome Measures

    1. Pancreatic sepsis [Three months]

    2. Length of hospitalization [From admission to discharge]

    3. Operation ratio [From admission to discharge]

    4. Cost of hospitalization [From admission to discharge]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 80 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Clinical diagnosis of severe acute pancreatitis

    • Consent informed

    Exclusion Criteria:
    • Diabetes mellitus

    • Allergy for any ingredient of PN or EN regimen

    • Pregnancy

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Sichuan Academy of Medical Sciences, Sichuan Provincial People's Hospital Chengdu Sichuan China 610072

    Sponsors and Collaborators

    • Sichuan Academy of Medical Sciences
    • Peking Union Medical College Hospital

    Investigators

    • Study Director: Bin Cai, M.D, Sichuan Academy of Medical Sciences
    • Principal Investigator: Hua Jiang, M.D, Sichuan Academy of Medical Sciences
    • Study Chair: Jun Zeng, M.D, Sichuan Academy of Medical Sciences

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    , ,
    ClinicalTrials.gov Identifier:
    NCT00995098
    Other Study ID Numbers:
    • SAMS-080384
    First Posted:
    Oct 15, 2009
    Last Update Posted:
    Nov 30, 2010
    Last Verified:
    Nov 1, 2010

    Study Results

    No Results Posted as of Nov 30, 2010